Amoxicillin Sodium and Sulbactam sodium for Injection

Amoxicillin Sodium and Sulbactam sodium for Injection
Product Description

Indications:This product is a combination preparation of Amoxicillin and Sulbactam Sodium. It is indicated for the following infections caused by β-lactamase-producing Staphylococcus, Klebsiella pneumoniae, other Streptococcus, Hemophilus Influenzae, Neisseria gonorrhoeae, Escherichia coli, Proteus species, Morganella species, Citrobacter species, Enterobacter species,Salmonella species, etc.:Upper Respiratory Tract Infections: sinusitis, tonsillitis, otitis media, laryngitis, pharyngitis; 
Lower respiratory tract infections: acute bronchitis, acute exacerbation of chronic bronchitis, bronchiectasis complicated with infection, pneumonia, empyema, lung abscess, etc.; 
Urogenital tract infections: acute pyelonephritis, acute exacerbation of chronic pyelonephritis, acute lower urinary tract infections, pelvic infections, etc.; Cutaneous and soft tissue infections: furuncles, abscesses, cellulitis, wound infections, etc.; 
Other systemic infections

Jiangsu Kingsley Pharmaceutical Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2026
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
CMO/CDMO
Distributor/Import Export
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Manufacturer
Medical Devices
Nutraceuticals
Pharmaceutical Company (generic finished products)
Specifications
  • Details
    Strength: 0.75g; 1.5g
    Antibacterial

  • Selling Points
    Advantages:1.Only one supplier outside China. Sole product identical to the innovator drug;
    2.Highly potent enzyme inhibition, with broad-spectrum antibacterial activity, and first-line drug for mild to moderate infections in clinical practice;
    3.Sulbactam can penetrate the blood-brain barrier, applicable for the treatment of central nervous system infections, it significantly enhances the antibacterial activity of amoxicillin and expands its antibacterial spectrum.
  • Supplied from
    China
  • Measured In
    US$

Jiangsu Kingsley Pharmaceutical Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2026
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
CMO/CDMO
Distributor/Import Export
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Manufacturer
Medical Devices
Nutraceuticals
Pharmaceutical Company (generic finished products)

More Products from Jiangsu Kingsley Pharmaceutical Co., Ltd. (2)

  • Aciclovir for Injection

    Product Aciclovir for Injection

    Advantages: 1.A classic anti-herpesvirus drug with potent activity against herpes simplex virus type 1/2 and varicella-zoster virus. It is the first-line drug, featuring rapid onset of action and precise targeting;
    2.High safety profile, mild adverse reactions, and broad population applicability; q...
  • Azithromycin for Injection

    Product Azithromycin for Injection

    Advantages: 1. 0.125g and 0.25g: unique production in China;2. The flagship product among macrolide antibiotics;
    3. A broad-spectrum antibiotic featuring a unique Trojan horse mechanism and a long post-antibiotic effect (PAE).

    Indications-This product is indicated for the following infec...